Pro-Dex (NASDAQ:PDEX) CFO Alisha Charlton Sells 2,300 Shares

Pro-Dex, Inc. (NASDAQ:PDEX) CFO Alisha Charlton sold 2,300 shares of the firm’s stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $61.30, for a total value of $140,990.00. Following the transaction, the chief financial officer owned 21,870 shares of the company’s stock, valued at $1,340,631. This trade represents a 9.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Pro-Dex Stock Performance

Shares of NASDAQ:PDEX opened at $59.84 on Friday. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.10 and a quick ratio of 2.45. The business’s fifty day moving average price is $62.39 and its two-hundred day moving average price is $57.68. Pro-Dex, Inc. has a fifty-two week low of $23.47 and a fifty-two week high of $77.00. The stock has a market capitalization of $191.49 million, a price-to-earnings ratio of 14.49 and a beta of 0.06.

Pro-Dex (NASDAQ:PDEX) last issued its earnings results on Thursday, September 3rd. The medical instruments supplier reported $0.87 EPS for the quarter, beating the consensus estimate of $0.67 by $0.20. Pro-Dex had a net margin of 17.62% and a return on equity of 25.13%. The company had revenue of $20.40 million for the quarter, compared to the consensus estimate of $19.20 million. As a group, analysts predict that Pro-Dex, Inc. will post 2.78 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in PDEX. Los Angeles Capital Management LLC acquired a new position in Pro-Dex during the 4th quarter worth about $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Pro-Dex in the second quarter worth about $50,000. Bank of America Corp DE raised its stake in shares of Pro-Dex by 173.3% in the second quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier’s stock worth $74,000 after acquiring an additional 1,073 shares during the last quarter. Wells Fargo & Company MN raised its stake in shares of Pro-Dex by 65.4% in the fourth quarter. Wells Fargo & Company MN now owns 2,314 shares of the medical instruments supplier’s stock worth $89,000 after acquiring an additional 915 shares during the last quarter. Finally, California State Teachers Retirement System acquired a new position in shares of Pro-Dex during the second quarter worth approximately $99,000. 15.28% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

PDEX has been the subject of several analyst reports. Wall Street Zen raised shares of Pro-Dex from a “hold” rating to a “buy” rating in a report on Saturday, June 13th. Zacks Research raised shares of Pro-Dex to a “hold” rating in a research note on Tuesday, May 19th. Finally, Weiss Ratings raised shares of Pro-Dex from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, September 4th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $70.00.

About Pro-Dex

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.